首页> 外文期刊>Gene therapy >Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
【24h】

Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.

机译:基于单纯疱疹病毒1型的扩增子载体用于传递小干扰RNA。

获取原文
获取原文并翻译 | 示例
           

摘要

Silencing of gene expression by small interfering RNAs (siRNAs) is rapidly becoming a powerful tool for genetic analysis of mammalian cells. The use of DNA-based plasmid vectors to achieve transient and stable expression of siRNA has been developed to avoid the problems of double-stranded oligonucleotides transfection. These vectors direct the transcription of small hairpin RNAs (shRNAs) from a polymerase-III (H1 or U6)-RNA gene promoter. However, numerous disadvantages remain, including low transfection efficiency and difficulty in transfecting primary cells. To overcome some of these problems, the use of viral vectors for siRNA delivery has been described. Retroviral, adenoviral, adeno-associated and herpes viral shRNAs delivery systems have been successfully used to silence genes, in vitro and in vivo. The use of a herpes simplex virus type 1 (HSV-1)-based amplicon vector for siRNA delivery into mammalian cells, using human polyomavirus BK (BKV)-transformed cells as a model system is described. The results demonstrate the ability of amplicon vectors to inhibit the expression of BKV T-Ag and tumorigenicity of BKV-transformed cells. We show that the use of the amplicon vector is highly efficient for the delivery of siRNA molecules. The unique ability of these vectors to deliver multiple copies of siRNA may provide a useful tool in the development of novel anticancer therapy.
机译:小干扰RNA(siRNA)沉默基因表达正迅速成为哺乳动物细胞遗传分析的有力工具。已经开发出使用基于DNA的质粒载体来实现siRNA的瞬时和稳定表达,以避免双链寡核苷酸转染的问题。这些载体指导小发夹RNA(shRNA)从聚合酶III(H1或U6)-RNA基因启动子的转录。然而,仍然存在许多缺点,包括低转染效率和难以转染原代细胞。为了克服这些问题中的一些,已经描述了病毒载体用于siRNA递送的用途。逆转录病毒,腺病毒,腺相关病毒和疱疹病毒shRNA递送系统已成功用于体外和体内沉默基因。描述了基于人单纯疱疹病毒BK(BKV)转化的细胞作为模型系统,使用基于单纯疱疹病毒1型(HSV-1)的扩增子载体将siRNA传递至哺乳动物细胞的方法。结果证明了扩增子载体抑制BKV T-Ag表达和BKV转化细胞致瘤性的能力。我们显示,使用扩增子载体对siRNA分子的递送非常有效。这些载体传递多拷贝的siRNA的独特能力可能为开发新型抗癌疗法提供有用的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号